Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(17%)

Phase Distribution

Ph phase_1
2
33%
Ph not_applicable
1
17%

Phase Distribution

2

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Phase 1Safety & dosage
2(66.7%)
N/ANon-phased studies
1(33.3%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Active(1)
Completed(3)
Terminated(1)
Other(1)

Detailed Status

Completed3
Not yet recruiting1
Terminated1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
75.0%
Most Advanced
Phase 1

Trials by Phase

Phase 12 (66.7%)
N/A1 (33.3%)

Trials by Status

not_yet_recruiting117%
completed350%
terminated117%
unknown117%

Recent Activity

0 active trials
Showing 5 of 6
completednot_applicable

Search for Biological Markers of Orosensory Perception of Fatty Acids in Healthy Subjects and Possible Modifications in Patients With Type 2 Diabetes and in Obese Non-diabetic Patients.

NCT02028975
not_yet_recruiting

Utilising AI Analysis of Sounds To prEdict heaRt failurE decOmpensation

NCT06555757
unknown

The Relations Among Endotoxin, Inflammatory Cytokines, Cognitive Markers and Brain MRI Changes in Subjects With Depressive Disorder

NCT06203015
terminatedphase_1

18F-MFBG PET Imaging of the Norepinephrine Transporter in Neural Crest and Neuroendocrine Tumors

NCT04258592
completed

Micro Ribosomal Nucleic Acid 155 in Non Hodgkin Lymphoma

NCT03185325
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT02028975Not Applicable

Search for Biological Markers of Orosensory Perception of Fatty Acids in Healthy Subjects and Possible Modifications in Patients With Type 2 Diabetes and in Obese Non-diabetic Patients.

Completed
NCT06555757

Utilising AI Analysis of Sounds To prEdict heaRt failurE decOmpensation

Not Yet Recruiting
NCT06203015

The Relations Among Endotoxin, Inflammatory Cytokines, Cognitive Markers and Brain MRI Changes in Subjects With Depressive Disorder

Unknown
NCT04258592Phase 1

18F-MFBG PET Imaging of the Norepinephrine Transporter in Neural Crest and Neuroendocrine Tumors

Terminated
NCT03185325

Micro Ribosomal Nucleic Acid 155 in Non Hodgkin Lymphoma

Completed
NCT03883776Phase 1

Al18F-NOTA-octreotide PET Imaging of the Somatostatin Receptor in Neuroendocrine Tumors

Completed

All 6 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
6